Screener
Merit Medical Systems MMSI Single Reportable — Nonoperating Income Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Merit Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Merit Medical Systems’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:23 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000856982-26-000025
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Cost of sales other(2) | 50,063 | 40,528 |
| Selling and marketing expenses | 73,957 | 64,929 |
| General and administrative expenses | 44,253 | 42,557 |
| Research and development expenses | 22,609 | 22,478 |
| Other operating expenses(3) | (179) | 1,023 |
| Other (income) expense — net | (9,389) | 3,075 |
| Income tax expense | 12,551 | 7,811 |
| Net income | $40,995 | $30,147 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Merit Medical Systems's single reportable — nonoperating income expense?
- Merit Medical Systems (MMSI) reported single reportable — nonoperating income expense of $9.39M in Q1 2026.
- What does single reportable — nonoperating income expense mean?
- This metric includes financial items outside of core operations, such as interest income, interest expense, and foreign exchange gains or losses. It reflects the impact of the company's capital structure and treasury management on the segment's bottom line. Understanding these items is necessary to isolate the performance of the core medical device business from financial market fluctuations.
Ask your AI about Merit Medical Systems's single reportable — nonoperating income expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude